Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience

CONCLUSIONS: Janus kinase inhibitors enrich the therapeutic portfolio for the treatment of atopic dermatitis. When carefully taking into consideration contraindications, side effects, and necessary laboratory controls, they represent a highly effective and safe treatment option for affected patients.PMID:35608635 | DOI:10.1007/s00105-022-05004-6
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - Category: Dermatology Authors: Source Type: research